Search research articles
Contact Us
Filters
Showing results (1-10 of 164) with videos related to
Page
of 17
Sort By:
European Urology
|
November 13, 2007
Editorial comment on: Three-year outcome following holmium laser enucleation of the prostate combined with mechanical morcellation in 330 consecutive patients
Theo M de Reijke
Urology
|
January 30, 2010
Editorial comment
Theo M de Reijke
The Journal of Urology
|
March 7, 2017
Editorial Comment
Theo M de Reijke
European Urology
|
December 13, 2007
Editorial comment on: Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy
Theo M de Reijke
European Urology
|
February 6, 2009
Editorial comment on: Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy
Theo M de Reijke
Therapeutic Advances in Urology
|
February 2, 2012
Best practice in the treatment of nonmuscle invasive bladder cancer
Anastasios Anastasiadis, Theo M de Reijke
Critical Reviews in Oncology/Hematology
|
August 23, 2002
EORTC prostate cancer trials: what have we learnt?
Theo M de Reijke, Laurence Collette
European Journal of Cancer (Oxford, England : 1990)
|
September 25, 2009
Treatment of local progression following radiotherapy
Theo M de Reijke, Thomas Wiegel
Expert Opinion on Emerging Drugs
|
May 8, 2018
Emerging intravesical drugs for the treatment of non muscle-invasive bladder cancer
Jasper Crijnen, Theo M De Reijke
European Urology
|
December 5, 2017
The Current State of Predicting Response on Bacillus Calmette-Guérin Treatment for Nonmuscle Invasive Bladder Cancer is Not Yet Useful for Patients but Attributes to Understanding Its Mechanisms of Action
Jorg R Oddens, Theo M de Reijke
Page
of 17
Search research articles
Search
Showing results (1-10 of 164) with videos related to
Sort By:
Page
of 17
European Urology
|
November 13, 2007
Editorial comment on: Three-year outcome following holmium laser enucleation of the prostate combined with mechanical morcellation in 330 consecutive patients
Theo M de Reijke
Urology
|
January 30, 2010
Editorial comment
Theo M de Reijke
The Journal of Urology
|
March 7, 2017
Editorial Comment
Theo M de Reijke
European Urology
|
December 13, 2007
Editorial comment on: Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy
Theo M de Reijke
European Urology
|
February 6, 2009
Editorial comment on: Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy
Theo M de Reijke
Therapeutic Advances in Urology
|
February 2, 2012
Best practice in the treatment of nonmuscle invasive bladder cancer
Anastasios Anastasiadis, Theo M de Reijke
Critical Reviews in Oncology/Hematology
|
August 23, 2002
EORTC prostate cancer trials: what have we learnt?
Theo M de Reijke, Laurence Collette
European Journal of Cancer (Oxford, England : 1990)
|
September 25, 2009
Treatment of local progression following radiotherapy
Theo M de Reijke, Thomas Wiegel
Expert Opinion on Emerging Drugs
|
May 8, 2018
Emerging intravesical drugs for the treatment of non muscle-invasive bladder cancer
Jasper Crijnen, Theo M De Reijke
European Urology
|
December 5, 2017
The Current State of Predicting Response on Bacillus Calmette-Guérin Treatment for Nonmuscle Invasive Bladder Cancer is Not Yet Useful for Patients but Attributes to Understanding Its Mechanisms of Action
Jorg R Oddens, Theo M de Reijke
Page
of 17